Table 1.
Statistics
| Analysis | Effect | Outcome | Data structure | Type of test | Power (α = 0.05) |
| NP at TR | squad | F(17,59) = 1.15 | a | 2 | 0.681 |
| session | F(6.1,421) = 13.0 | a | 1 | 1 | |
| session × drug1 | F(18,421) = 1.59 | a | 1 | 0.935 | |
| session × drug2 | F(6.1,421) = 1.25 | a | 1 | 0.499 | |
| session × drug1 × drug2 | F < 1 | a | 1 | 0.617 | |
| drug1 | F < 1 | a | 1 | 0.089 | |
| drug2 | F < 1 | a | 1 | 0.052 | |
| drug1 × drug2 | F < 1 | a | 1 | 0.096 | |
| CS at TR | session | F(8,552) = 1.20 | b | 1 | 0.559 |
| drug1 | F < 1 | b | 1 | 0.234 | |
| drug2 | F(1,69) = 2.52 | b | 1 | 0.346 | |
| drug1 × drug2 | F < 1 | b | 1 | 0.234 | |
| session × drug1 | F(24,552) = 1.56 | b | 1 | 0.971 | |
| session x drug1 x drug2 | F(24,552) = 1.56 | b | 1 | 0.971 | |
| NP at React | squad | F(17,59) = 1.54 | b | 2 | 0.836 |
| drug1 | F < 1 | b | 2 | 0.159 | |
| CS at React | drug1 | F(3,76) = 1.45 | b | 2 | 0.37 |
| NP at React | drug2 | F < 1 | b | 3 | 0.077 |
| drug1 × drug2 | F < 1 | b | 3 | 0.146 | |
| CS at React | drug2 | F < 1 | b | 3 | 0.086 |
| drug1 × drug2 | F < 1 | b | 3 | 0.156 | |
| LP at ANR | squad | F(17,59) = 1.08 | a | 2 | 0.644 |
| drug1 × drug2 | F(3,69) = 3.40 | a | 1 | 0.743 | |
| lever × drug1 × drug2 | F(38.4,69.0) = 3.11 | a | 1 | 0.701 | |
| drug1 | F(3,69) = 1.24 | a | 1 | 0.319 | |
| lever × drug1 | F(14.4,69.0) = 1.16 | a | 1 | 0.3 | |
| drug2 | F(1,69) = 2.67 | a | 1 | 0.364 | |
| lever × drug2 | F < 1 | a | 1 | 0.052 | |
| NP at ANR | drug1 | F < 1 | a | 1 | 0.116 |
| drug2 | F(1,69) = 1.44 | a | 1 | 0.212 | |
| drug1 × drug2 | F(3,69) = 1.72 | a | 1 | 0.498 | |
| session × drug1 | F(16.7,386) = 1.71 | a | 1 | 0.941 | |
| LP/VEH | ANI | F(1,33) = 5.33 | a | 1 | 0.61 |
| lever × session in VEH/VEH | F(3.6,89.6) = 6.27 | a | 1 | 0.978 | |
| lever × session in VEH/ANI | F(2.4,19.4) = 1.8 | a | 1 | 0.36 | |
| NP/VEH | ANI | F(1,33) = 2.05 | a | 1 | 0.285 |
| session × ANI | F < 1 | a | 1 | 0.265 | |
| LP/SCH | SCH × ANI | F(1,45) = 6.75 | a | 1 | 0.720 |
| ANI | F < 1 | a | 1 | 0.131 | |
| lever × ANI | F < 1 | a | 1 | 0.078 | |
| lever × session × ANI | F(2.99,35.9) = 1.60 | a | 1 | 0.384 | |
| lever | F(1,12) = 36.7 | a | 1 | 1 | |
| lever × session | F(2.99,35.9) = 3.88 | a | 1 | 0.78 | |
| NP/SCH | ANI | F(1,12) = 1.55 | a | 1 | 0.209 |
| session × ANI | F < 1 | a | 1 | 0.124 | |
| LP/RAC | RAC × ANI | F(1,46) = 7.26 | a | 1 | 0.751 |
| lever | F(1,13) = 23.1 | a | 1 | 0.993 | |
| lever × ANI | F(1,13) = 6.04 | a | 1 | 0.623 | |
| ANI | F < 1 | a | 1 | 0.081 | |
| NP/RAC | ANI | F(1,13) = 2.64 | a | 1 | 0.324 |
| session × ANI | F < 1 | a | 1 | 0.319 | |
| LP/FLU | FLU × ANI | F(1,44) = 2.26 | a | 1 | 0.312 |
| ANI | F(1,11) = 7.48 | a | 1 | 0.702 | |
| NP/FLU | ANI | F(1,11) = 1.36 | a | 1 | 0.187 |
| session × ANI | F < 1 | a | 1 | 0.231 | |
| LP/Drug1 | drug1 | F < 1 | a | 1 | 0.249 |
| lever × drug1 | F(3,43) = 1.43 | a | 1 | 0.352 | |
| session × drug1 | F(15.6,224) = 1.11 | a | 1 | 0.72 | |
| lever × session × drug1 | F < 1 | a | 1 | 0.5 | |
| LP/ANI | drug1 | F(3,26) = 3.01 | a | 1 | 0.639 |
| lever × drug1 | F(3,26) = 2.53 | a | 1 | 0.557 | |
| VEH/ANI | lever | F(1,8) = 2.13 | a | 1 | 0.251 |
| FLU/ANI | lever | F(1,7) = 3.06 | a | 1 | 0.327 |
| SCH/ANI | lever | F(1,5) = 29.6 | a | 1 | 0.989 |
| RAC/ANI | lever | F(1,6) = 39.6 | a | 1 | 0.999 |
a, Normal distribution after transformation; b, normal distribution; 1, repeated-measures ANOVA; 2, one-way ANOVA; 3, two-way ANOVA. NP, nosepoke; TR, training session; React, memory reactivation session; LP, lever pressing; ANR, acquisition of a new response.